Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sleep disorder
ICD-10 F13.282 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sleep disorder.
F13.282 refers to a condition characterized by a dependence on sedative, hypnotic, or anxiolytic substances, which leads to a sleep disorder induced by these substances. Patients with this diagnosis often exhibit a pattern of compulsive use of medications such as benzodiazepines or barbiturates, resulting in tolerance and withdrawal symptoms. The sleep disorder may manifest as insomnia, excessive daytime sleepiness, or altered sleep architecture, which can further complicate the patient's overall health. This condition is often seen in individuals with a history of anxiety or sleep disorders, and it may require a multidisciplinary approach for effective management, including behavioral therapies and gradual tapering of the offending substances. Accurate diagnosis and coding are crucial for appropriate treatment planning and insurance reimbursement.
Comprehensive psychiatric evaluation, including substance use history and sleep assessment.
Patients presenting with anxiety disorders who have been prescribed benzodiazepines for extended periods.
Consideration of co-occurring mental health disorders and the impact of substance use on treatment outcomes.
Detailed sleep studies and assessments to confirm the sleep disorder diagnosis.
Patients experiencing chronic insomnia linked to sedative use.
Need for collaboration with psychiatry for comprehensive management of dependence and sleep issues.
Used for follow-up visits for patients with sedative dependence and sleep disorders.
Detailed history and examination, including substance use and sleep patterns.
Psychiatric evaluations may require additional documentation of mental status and risk assessments.
Dependence refers to a physiological and psychological reliance on a substance, characterized by tolerance and withdrawal symptoms, while abuse involves the harmful use of a substance without necessarily meeting the criteria for dependence. F13.282 specifically addresses dependence with an induced sleep disorder.
